1. Home
  2. REAX vs AVDL Comparison

REAX vs AVDL Comparison

Compare REAX & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REAX
  • AVDL
  • Stock Information
  • Founded
  • REAX 2018
  • AVDL 2015
  • Country
  • REAX United States
  • AVDL Ireland
  • Employees
  • REAX N/A
  • AVDL N/A
  • Industry
  • REAX
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • REAX
  • AVDL Health Care
  • Exchange
  • REAX Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • REAX 800.1M
  • AVDL 861.4M
  • IPO Year
  • REAX N/A
  • AVDL 1996
  • Fundamental
  • Price
  • REAX $4.49
  • AVDL $13.69
  • Analyst Decision
  • REAX Strong Buy
  • AVDL Strong Buy
  • Analyst Count
  • REAX 3
  • AVDL 7
  • Target Price
  • REAX $6.33
  • AVDL $19.00
  • AVG Volume (30 Days)
  • REAX 1.2M
  • AVDL 1.2M
  • Earning Date
  • REAX 08-07-2025
  • AVDL 08-07-2025
  • Dividend Yield
  • REAX N/A
  • AVDL N/A
  • EPS Growth
  • REAX N/A
  • AVDL N/A
  • EPS
  • REAX N/A
  • AVDL N/A
  • Revenue
  • REAX $1,617,846,000.00
  • AVDL $221,075,000.00
  • Revenue This Year
  • REAX $44.55
  • AVDL $56.78
  • Revenue Next Year
  • REAX $16.68
  • AVDL $30.46
  • P/E Ratio
  • REAX N/A
  • AVDL N/A
  • Revenue Growth
  • REAX 72.57
  • AVDL 132.35
  • 52 Week Low
  • REAX $3.80
  • AVDL $6.38
  • 52 Week High
  • REAX $6.75
  • AVDL $16.66
  • Technical
  • Relative Strength Index (RSI)
  • REAX 62.72
  • AVDL 78.08
  • Support Level
  • REAX $3.87
  • AVDL $10.79
  • Resistance Level
  • REAX $4.58
  • AVDL $13.94
  • Average True Range (ATR)
  • REAX 0.21
  • AVDL 0.65
  • MACD
  • REAX 0.06
  • AVDL 0.21
  • Stochastic Oscillator
  • REAX 87.41
  • AVDL 85.83

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: